Skip to main content

Pure Bioscience, Inc.

PURE
Exchange
OTC
Industry
Miscellaneous Chemical Products
SEC CIK
0001006028

No open-market purchases or sales by Pure Bioscience, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Pure Bioscience, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Pure Bioscience, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Pure Bioscience, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Bartlett Robert FCEO and President50,000IndirectAug 22, 20240
Lee Tom YDirector, 10% Owner5,001,843Aug 22, 20240
Elliott Mark StuartVice President, Finance–Aug 22, 20240
Chen IvanDirector750,000Aug 22, 20240
Myers Thomas RichardExec VP, Tech & Development–Aug 22, 20240
Rendall DavidDirector402,371Aug 22, 20240
Blotner BernardDirector10,000IndirectAug 22, 20240
Zehr DarinDirector–Aug 22, 20240
Taylor KristinDirector–Oct 4, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 22, 2023 (view filing)5:55 PM ETMar 211 dayBlotner BernardDirectorPPurchase+10.0K$0.1299+$1.30KNew position10.0K after
Mar 22, 2023 (view filing)5:53 PM ETMar 22Same dayBartlett Robert FCEOPPurchase+50.0K$0.155+$7.75KNew position50.0K after
Dec 19, 2022 (view filing)6:48 PM ETDec 154 daysLee Tom YChief Executive OfficerPPurchase+50.0K$0.131+$6.55K+1.0%5.00M after
Mar 22, 2022 (view filing)9:49 PM ETMar 16-216 daysLateLee Tom YChief Executive OfficerPPurchase+219.5K$0.1951+$42.8K+4.6%4.95M after3 lots